SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-192766
Filing Date
2004-11-10
Accepted
2004-11-10 15:45:50
Documents
5
Period of Report
2004-11-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR CORTEX PHARMACEUTICALS, INC. d8k.htm 8-K 20528
2 LETTER FROM ERNST & YOUNG LLP dex161.htm EX-16.1 4185
3 PRESS RELEASE, DATED NOVEMBER 10, 2004 dex991.htm EX-99.1 9784
4 GRAPHIC g4312443124-1.jpg GRAPHIC 4199
5 GRAPHIC g43124image2.jpg GRAPHIC 7498
  Complete submission text file 0001193125-04-192766.txt   48414
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 041133114
SIC: 2834 Pharmaceutical Preparations